Medical Condition News

RSS

Scientists turn human stomach cells into insulin-producing beta cells

Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and estimated to affect 9.5 million people worldwide.

6 Nov 2025

Finerenone offers hope for kidney protection in patients with type 1 diabetes

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease.

6 Nov 2025

Scientists map gut microbiota associated with coronary artery disease

Nearly 20 million people die every year from cardiovascular diseases, the leading cause of death worldwide.

6 Nov 2025

Social media spreads both awareness and misinformation about allergies and asthma

From rare tick-borne meat allergy to everyday asthma, millions of people turn to social media for health advice.

6 Nov 2025

Studies reveal how hereditary angioedema disrupts the lives of children and families

Two new studies being presented at the 2025 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Orlando shed light on how hereditary angioedema (HAE) – a rare, potentially life-threatening disease which causes unpredictable swelling – profoundly affects the daily lives, emotional wellbeing, and medical experiences of young patients and their caregivers.

6 Nov 2025

Can creatine help with depression? New review says results are inconclusive

Creatine supplementation may modestly reduce depressive symptoms, but the effect is small, uncertain, and likely influenced by study bias. The evidence remains of very low quality, highlighting the need for larger, well-designed clinical trials.

6 Nov 2025

Alzheimer’s breakthrough reveals how tweaking one gene shields brain connections

Lowering the transcription factor PU.1 reprograms microglia into a neuroprotective, lymphoid-like state that compacts amyloid, blocks tau spread, and preserves synapses in Alzheimer’s disease. Microglial CD28 signaling helps restrain inflammation, revealing a regulatory switch that may inform future immunotherapies targeting microglia rather than neurons.

6 Nov 2025

Gluten-free guide lifts diet quality for children but lasting change needs support

A new pilot RCT in children with celiac disease found that a single counselling session using a Gluten-Free Food Guide (GFFG) temporarily improved diet quality, variety, and milk intake but the benefits faded within six months. Ongoing support may be essential for lasting dietary change.

6 Nov 2025

Veterans deployed to Iraq and Afghanistan face higher risk of chronic respiratory conditions

U.S. Veterans who served in Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) face an increased risk of developing several chronic respiratory conditions, according to new research presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Orlando.

6 Nov 2025

Thunderstorms can trigger sharp increases in asthma-related emergency department visits

A new study finds that thunderstorms can trigger sharp increases in asthma-related emergency department (ED) visits, underscoring the importance of storm preparedness for people with asthma. The research is being presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Orlando.

6 Nov 2025

Allergic conditions linked to higher risk of complications after surgery

Two new studies being presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) show that people with allergic conditions - including eczema, asthma, and hay fever - may face more problems after certain types of surgery.

6 Nov 2025

Adolescents who experience migraines more likely to have high blood pressure

A nationwide study from the Hebrew University of Jerusalem has found that adolescents who experience migraines are three times more likely to have high blood pressure.

6 Nov 2025

American Cancer Society releases first-ever U.S. Tobacco Atlas

The American Cancer Society (ACS) today announced the inaugural release of The U.S. Tobacco Atlas, a fact-based, digital scientific resource offering comprehensive data and insights on tobacco use, control policies, and their impact nationwide. The report notes that cigarette smoking among U.S. adults dropped from 42% in 1965 to 11% in 2023.

6 Nov 2025

Novel therapy for psychosis tackles disturbing mental imagery

A pioneering therapy targeting distressing and disturbing mental images for people with psychosis could lead to a transformative intervention for a condition estimated to cost England almost £12 billion a year.

6 Nov 2025

Tropical cyclone exposure associated with higher risk of death from various causes

Beyond direct injuries, exposure to tropical cyclones is associated with higher risks of death across a range of causes including kidney, heart and lung diseases, neuropsychiatric conditions, and diabetes, finds a study published in The BMJ's climate issue today.

6 Nov 2025

Researchers identify patient response patterns to novel schizophrenia medication

Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so profoundly that it can distort a person's sense of reality.

6 Nov 2025

Combination therapy offers hope for ending lifelong chronic lymphocytic leukemia treatment

Ianalumab targets the B-cell activating factor receptor (BAFR) and ibrutinib belongs to a class of therapeutics called Bruton's tyrosine kinase inhibitors (BTKi).

6 Nov 2025

Global report reveals a decade of uneven progress in advanced breast cancer care

The ABC Global Alliance today launched the Advanced Breast Cancer (ABC) Global Decade Report 2015–2025 - a landmark global assessment revealing a decade of remarkable scientific progress that has transformed ABC care for some patients in some countries, while many others around the world have yet to benefit.

5 Nov 2025

Heart damage during middle age linked to greater dementia risk in later life

People with signs of damage to their heart during middle age are more likely to develop dementia in later life, according to a new study led by UCL (University College London) researchers.

5 Nov 2025

Newly identified microglia subtype offers protection against Alzheimer’s disease

In Alzheimer's disease, the leading cause of dementia, microglia-the brain's immune defenders-can act as both protectors and aggressors, shaping how the disease progresses.

5 Nov 2025

Medical Condition News

Scientists turn human stomach cells into insulin-producing beta cells

Finerenone offers hope for kidney protection in patients with type 1 diabetes

Scientists map gut microbiota associated with coronary artery disease

Social media spreads both awareness and misinformation about allergies and asthma

Studies reveal how hereditary angioedema disrupts the lives of children and families

Can creatine help with depression? New review says results are inconclusive

Alzheimer’s breakthrough reveals how tweaking one gene shields brain connections

Gluten-free guide lifts diet quality for children but lasting change needs support

Veterans deployed to Iraq and Afghanistan face higher risk of chronic respiratory conditions

Thunderstorms can trigger sharp increases in asthma-related emergency department visits

Allergic conditions linked to higher risk of complications after surgery

Adolescents who experience migraines more likely to have high blood pressure

American Cancer Society releases first-ever U.S. Tobacco Atlas

Novel therapy for psychosis tackles disturbing mental imagery

Tropical cyclone exposure associated with higher risk of death from various causes

Researchers identify patient response patterns to novel schizophrenia medication

Combination therapy offers hope for ending lifelong chronic lymphocytic leukemia treatment

Global report reveals a decade of uneven progress in advanced breast cancer care

Heart damage during middle age linked to greater dementia risk in later life

Newly identified microglia subtype offers protection against Alzheimer’s disease

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News